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Abstract
Background: IL-18 is a multifunctional cytokine capable of inducing either Th1 or Th2 polarization depending on the immunologic milieu.
IL-18 is detected at the materno-fetal interface very soon in early pregnancy. Two polymorphisms in the promoter region of the IL-18 gene at
positions of ÿ607 and ÿ137 appear to have functional impacts.
Objective: This study attempts to evaluate the frequency of these two polymorphisms in the IL-18 gene promoter in patients with recurrent
spontaneous abortion (RSA) and normal pregnant women.
Subjects and methods: One hundred and two RSA patients and 103 healthy pregnant women were enrolled in this study. Single nucleotide
polymorphisms of the IL-18 gene at positions ÿ607 (C/A) and ÿ137 (G/C) were analyzed by the sequence-specific PCR method.
Results: There was no significant association between the allele, genotype, and haplotype frequencies of the two single nucleotide
polymorphisms (SNPs) in the IL-18 gene promoter and RSA.
Conclusion: The results of this study showed that IL-18 gene promoter polymorphisms at positions ÿ607 and ÿ137 did not confer
susceptibility to RSA in southern Iranian patients.
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1. Introduction
Recurrent spontaneous abortion (RSA), the occurrence of
three or more consecutive pregnancy losses in the first
trimester, occurs in approximately 1% of pregnant women
worldwide. A series of etiological factors responsible for
RSA are divided into the embryologically driven causes
(abnormal embryonic karyotypes) and maternally driven
ones affecting the endometrium and/or placenta (luteal
phase defect, hyperprolactinemia, hyperhomocysteinemia,
uterine anomalies, coagulation disorders, autoimmune
diseases, endocrine disorders, and endometrial defects)
[1]. Despite these well-established pathophysiological
mechanisms, the exact underlying etiology is still poorly
understood in up to 50% of RSA cases. Recent studies shed
light on the immune mechanism as a cause of a proportion of
these idiopathic pregnancy losses [1–4].
Production of cytokines and the distribution of the
immune cells during pregnancy appeared to be critical in
pregnancy outcome [1–4]. Interleukin (IL)-18, initially
known as an interferon (IFN)-g inducing factor, is a member
of the IL-1 cytokine family, which is produced by a variety
of immune and non-immune cells. It is a unique cytokine
capable of enhancing either Th1 or Th2 differentiation
depending on the immunologic milieu. It also augments the
cytotoxic actions of natural killer and CD8+ T cells [5,6].
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